Latest Flamel Technologies S.A. (FLML) Headlines Flamel

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Flamel Technologies S.A. (FLML) Headlines

Flamel Technologies prices public offering at USD9.75 per ADS
M2 - Mon Mar 10, 4:12AM CDT
Drug delivery company Flamel Technologies (NASDAQ:FLML) said on Friday that it has priced its offering of American Depositary Shares (ADSs), representing 10,800,000 ordinary shares.

Flamel Technologies, S.A. Announces Pricing of Public Offering of American Depositary Shares
Marketwire - Fri Mar 07, 7:39AM CST
Flamel Technologies, S.A. (NASDAQ: FLML) today announced the pricing of an underwritten offering of American Depositary Shares (ADSs), representing 10,800,000 ordinary shares, at a price to the public of $9.75 per ADS. All of the ADSs in this offering are to be sold by Flamel. Flamel has granted the underwriters a 30-day option to purchase up to an additional 1,600,000 ADSs to cover over-allotments, if any, in connection with the offering. The offering is expected to close on March 12, 2014, subject to customary closing conditions.

Flamel Technologies plans to issue ADSs in public offering
M2 - Fri Mar 07, 6:02AM CST
Drug delivery company Flamel Technologies SA (NASDAQ:FLML) said on Thursday that it intends to sell American Depositary Shares (ADSs), representing its ordinary shares, in an underwritten public offering.

Flamel Technologies, S.A. Announces Proposed Underwritten Public Offering of American Depositary Shares
Marketwire - Thu Mar 06, 3:01PM CST
Flamel Technologies, S.A. (NASDAQ: FLML) today announced that it is offering to sell American Depositary Shares (ADSs), representing its ordinary shares, in an underwritten public offering. In connection with the offering, Flamel intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the ADSs offered in the public offering to cover over-allotments, if any.

Flamel Technologies Up 57.5% Since SmarTrend Uptrend Call (FLML)
Comtex SmarTrend(R) - Fri Jan 17, 4:43PM CST
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on November 14th, 2013 at $6.74. In approximately 2 months, Flamel Technologies has returned 57.54% as of today's recent price of $10.61.

Flamel Technologies (FLML) in Focus: Stock Jumps 8.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 13, 7:37AM CST
Flamel Technologies SA was a big mover last session, as the company saw its shares rise almost 9% on the day.

Flamel Technologies Up 48.3% Since SmarTrend Uptrend Call (FLML)
Comtex SmarTrend(R) - Fri Jan 10, 10:59AM CST
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on November 14th, 2013 at $6.74. In approximately 2 months, Flamel Technologies has returned 48.33% as of today's recent price of $9.99.

New IGP Sets His Priorities, Warns Unethical Officers
by Abdulwakil Saiboko - All Africa Global Media - Thu Jan 09, 10:36PM CST
THE newly-appointed Inspector- General of Police (IGP), Mr Ernest Mangu, has outlined his priorities, warning police over unethical behaviour, saying severe measures will be taken against violators.

Flamel Technologies SA (FLML) Jumps: Stock Adds 8.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 06, 8:39AM CST
Flamel Technologies SA was a big mover last session, as its shares rose almost 9% on the day.

Flamel Technologies Shares Up 22.0% Since SmarTrend's Buy Recommendation (FLML)
Comtex SmarTrend(R) - Fri Jan 03, 9:52AM CST
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on November 14th, 2013 at $6.74. In approximately 2 months, Flamel Technologies has returned 22.05% as of today's recent price of $8.22.

Flamel Technologies Shares Up 19.2% Since SmarTrend's Buy Recommendation (FLML)
Comtex SmarTrend(R) - Fri Dec 27, 9:25AM CST
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on November 14th, 2013 at $6.74. In approximately 1 month, Flamel Technologies has returned 19.23% as of today's recent price of $8.03.

16.6% Return Seen to Date on SmarTrend Flamel Technologies Call (FLML)
Comtex SmarTrend(R) - Thu Dec 19, 9:54AM CST
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on November 14th, 2013 at $6.74. In approximately 1 month, Flamel Technologies has returned 16.62% as of today's recent price of $7.85.

Flamel Technologies enters into USD15m line of credit with Broadfin Capital
M2 - Thu Dec 05, 10:33AM CST
Drug delivery company Flamel Technologies (NASDAQ:FLML) reported on Wednesday the execution of a USD15.0m secured line of credit with Broadfin Capital, its current shareholder.

Flamel Technologies Announces $15 Million Line of Credit
Marketwire - Wed Dec 04, 3:05PM CST
Flamel Technologies (NASDAQ: FLML) today announced that it established a USD $15.0 million secured line of credit with Broadfin Capital, a current Flamel shareholder. The $15.0 million credit facility can be drawn in three tranches of $5.0 million each. The Company will draw $5.0 million initially and can draw up to two additional $5.0 million tranches prior to August 15, 2014, subject to satisfaction of funding conditions. This line of credit financing will allow the Company to continue its investment in R&D projects and the launch of its first-NDA approved product, Bloxiverz(TM). The interest rate on any outstanding loan is 12.5% and the loan must be repaid on or before November 15, 2015. There is no cost for undrawn capital or any penalty or premium for early repayment. For each tranche of the line of credit drawn by Flamel, Broadfin Capital will also receive a royalty of less than 1.0% (subject to a maximum cumulative royalty of 2.0% if all three tranches are drawn) on net sales of Bloxiverz and the other products resulting from the R&D projects of the former Eclat Pharmaceuticals, subject to required regulatory approvals and sales of these products.

Nasdaq stocks posting largest percentage increases
AP - Tue Nov 12, 5:19PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:

Flamel Technologies Announces Third Quarter 2013 Results
Marketwire - Thu Oct 31, 6:30AM CDT
Flamel Technologies (NASDAQ: FLML) today announced its financial results for the third quarter of 2013. Highlights from the quarter include:

Uptrend Call Working As Flamel Technologies Stock Rises 19.9% (FLML)
Comtex SmarTrend(R) - Wed Oct 30, 4:58PM CDT
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on June 3rd, 2013 at $5.54. In approximately 5 months, Flamel Technologies has returned 19.86% as of today's recent price of $6.64.

24.9% Return Seen to Date on SmarTrend Flamel Technologies Call (FLML)
Comtex SmarTrend(R) - Wed Oct 23, 11:05AM CDT
SmarTrend identified an Uptrend for Flamel Technologies (NASDAQ:FLML) on June 3rd, 2013 at $5.54. In approximately 5 months, Flamel Technologies has returned 24.91% as of today's recent price of $6.92.

Flamel Technologies Announces Projected Release Date of Third Quarter 2013 Results and Conference Call
Marketwire - Thu Oct 17, 6:01AM CDT
Flamel Technologies (NASDAQ: FLML) expects to release certain financial results for the third quarter of 2013 on Thursday, October 31, 2013, before the market open. A conference call to discuss these results has been scheduled for Thursday, October 31st at 10:00 AM (Eastern Daylight Time). A question and answer period will follow management's prepared remarks.

Avadel Pharmaceuticals plc (AVDL) Stock Research Links

AVDL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 47

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 28

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 63

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 36

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 54

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 39

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 42

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading

Top 5 Most Recently Viewed Articles

Deere Settles $9.93 Million SEC Bribery Investigation Case

Updated Category News Views 111

Deere settles SEC bribery case for $9.93 million Deere (NYSE: DE) has agreed to pay $9.93 million to the U.S. Securities and Exchange Commission (SEC) to resolve a Foreign Corrupt Practices Act (FCPA) matter. The action closes a significant investigation and underscores how complex it can be for global companies to operate across borders while meeting U.S. and local rules...

Continue Reading
IperionX Quarterly Report Highlights Growth and Expansion Plans

Updated Category News Views 135

IperionX Limited Quarterly Update: Key Highlights CHARLOTTE, N.C. - IperionX Limited (NASDAQ: IPX, ASX: IPX) shares its quarterly report, highlighting significant progress achieved up to June 30, 2025. This period marks a transformative phase in the company, underlining a commitment to sustainable practices and growth in the titanium industry. Advancements in Commercial...

Continue Reading
Generate:Biomedicines Partners with Novartis for AI Therapeutics

Updated Category News Views 132

Generate:Biomedicines and Novartis Announce Partnership Generate:Biomedicines is thrilled to share its new collaboration with Novartis, aiming to harness its cutting-edge generative AI platform to discover protein therapeutics. This partnership is set to address various disease areas by developing potential first- and best-in-class therapeutic molecules. Revolutionizing...

Continue Reading
Join Dr. Salehani for an Exclusive Evening of Digital Dentistry

Updated Category News Views 258

Dr. David Salehani Hosts Exclusive Study Club Event Dr. David Salehani is excited to host a specialized Study Club dedicated to the dental community. This exclusive event features Dr. Storm Hagen, a prominent expert in the field of digital dentistry, and will include a captivating lecture on 3D printing and digital workflows in modern dentistry. Attendees can expect an...

Continue Reading
Free Health Screenings for Cholesterol Detection in Orlando

Updated Category News Views 173

Free Health Screenings for Cholesterol Detection in Orlando In a significant health initiative, Care Access is bringing its Heart & Kidney Health Screening program to residents of Orlando. This innovative approach is designed to enhance awareness and provide testing for crucial health risk factors, particularly focusing on a dangerous type of cholesterol known as...

Continue Reading